Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort

Objective: The objective of this study was to assess longitudinal change in clinical and dopamine transporter imaging outcomes in early, untreated PD. Methods: We describe 5‐year longitudinal change of the MDS‐UPDRS and other clinical measures using results from the Parkinson's Progression Mark...

Descripción completa

Detalles Bibliográficos
Autores principales: Simuni, Tanya, Siderowf, Andrew, Lasch, Shirley, Coffey, Chris S., Caspell‐Garcia, Chelsea, Jennings, Danna, Tanner, Caroline M., Trojanowski, John Q., Shaw, Leslie M., Seibyl, John, Schuff, Norbert, Singleton, Andrew, Kieburtz, Karl, Toga, Arthur W., Mollenhauer, Brit, Galasko, Doug, Chahine, Lana M., Weintraub, Daniel, Foroud, Tatiana, Tosun, Duygu, Poston, Kathleen, Arnedo, Vanessa, Frasier, Mark, Sherer, Todd, Chowdhury, Sohini, Marek, Kenneth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001458/
https://www.ncbi.nlm.nih.gov/pubmed/29572948
http://dx.doi.org/10.1002/mds.27361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001458/
https://www.ncbi.nlm.nih.gov/pubmed/29572948
http://dx.doi.org/10.1002/mds.27361

Ejemplares similares